Nigerian journal of clinical practice · 2021
Oxidative stress parameters and antioxidant enzyme levels in patients with central serous chorioretinopathy.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Urfalioglu S, Baylan F Alkan, Guler M
Аннотация
BACKGROUND: Central serous chorioretinopathy (CSC) is a posterior segment disease caused by macular serous detachment as a result of inflammation and oxidative stress due to hypoperfusion of choriocapillaris.
AIMS: The aim of the study was to assess the oxidant/antioxidant balance in CSC.s.
MATERIALS AND METHODS: The plasma levels of malonyl dialdehyde (MDA), glutathione peroxidase (GSH-Px), myeloperoxidase (MPO), catalase (CAT), and xanthine oxidase (XO) were assessed in 21 patients with CSC (group S) and in 23 individuals without any eye pathology as the control group (group C). Furthermore, the disease was staged through routine opthalmologic examination as well as optic coherence tomography (OCT).
RESULTS: MDA levels were significantly higher in group S (25.36 ± 4.51 nmol/ml), when compared with group C (22.79 ± 3.23 nmol/ml) (P = 0.035). In addition, the levels of CAT were significantly lower in group S (8.28 ± 5.85 U/ml) when compared to group C (14.02 ± 8.61 (P = 0.014).
CONCLUSION: Prevention of the oxidative injury may be considered among the associated treatment options under the light of the changes detected in the oxidative/antioxidative parameters.
AIMS: The aim of the study was to assess the oxidant/antioxidant balance in CSC.s.
MATERIALS AND METHODS: The plasma levels of malonyl dialdehyde (MDA), glutathione peroxidase (GSH-Px), myeloperoxidase (MPO), catalase (CAT), and xanthine oxidase (XO) were assessed in 21 patients with CSC (group S) and in 23 individuals without any eye pathology as the control group (group C). Furthermore, the disease was staged through routine opthalmologic examination as well as optic coherence tomography (OCT).
RESULTS: MDA levels were significantly higher in group S (25.36 ± 4.51 nmol/ml), when compared with group C (22.79 ± 3.23 nmol/ml) (P = 0.035). In addition, the levels of CAT were significantly lower in group S (8.28 ± 5.85 U/ml) when compared to group C (14.02 ± 8.61 (P = 0.014).
CONCLUSION: Prevention of the oxidative injury may be considered among the associated treatment options under the light of the changes detected in the oxidative/antioxidative parameters.